Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LF.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LF.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.3.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.2.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LQ.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LQ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LQ.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MD.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MD.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MD.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LZ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LZ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MB.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MB.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MB.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.3.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.2.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
unclassifiableNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
unclassifiableNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
unclassifiableNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KS.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KS.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HH.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used